Citizens Financial Group Inc. RI Boosts Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Citizens Financial Group Inc. RI boosted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 26.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,971 shares of the exchange traded fund’s stock after purchasing an additional 825 shares during the quarter. Citizens Financial Group Inc. RI’s holdings in SPDR S&P Biotech ETF were worth $368,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently bought and sold shares of the company. Avoro Capital Advisors LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 4th quarter valued at $396,844,000. Healthcare of Ontario Pension Plan Trust Fund grew its holdings in shares of SPDR S&P Biotech ETF by 30.3% during the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock worth $297,575,000 after purchasing an additional 730,000 shares in the last quarter. Jane Street Group LLC increased its position in shares of SPDR S&P Biotech ETF by 68.7% in the first quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock worth $91,197,000 after purchasing an additional 391,333 shares during the last quarter. Bessemer Group Inc. raised its stake in SPDR S&P Biotech ETF by 1.7% in the first quarter. Bessemer Group Inc. now owns 922,871 shares of the exchange traded fund’s stock valued at $87,572,000 after purchasing an additional 15,794 shares in the last quarter. Finally, Mirae Asset Securities USA Inc. bought a new stake in SPDR S&P Biotech ETF during the second quarter valued at approximately $55,626,000.

SPDR S&P Biotech ETF Price Performance

XBI stock opened at $100.81 on Thursday. The firm has a 50 day simple moving average of $98.78 and a two-hundred day simple moving average of $93.87. The stock has a market cap of $7.68 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a one year low of $63.80 and a one year high of $103.52.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.